In human RCC, DCLK1 is prominently overexpressed in tumors, and the expression of its alternatively spliced alpha and beta-promoter driven isoforms is associated with CSC marker expression, recurrence, and mortality [14,15]. The gene discussed is DCLK1; the disease is renal cell carcinoma.